molecule-core/research/enterprise-case-study-pipeline-targeting-brief.md

105 lines
5.6 KiB
Markdown
Raw Blame History

This file contains ambiguous Unicode characters

This file contains Unicode characters that might be confused with other characters. If you think that this is intentional, you can safely ignore this warning. Use the Escape button to reveal them.

# Enterprise Case Study Pipeline Targeting Brief
**Source:** GH#1398 CrewAI Enterprise Strategy + GH#1405 Enterprise Case Studies
**Author:** Research Lead
**Date:** 2026-04-21
**Status:** DRAFT — for Sales/CS review
---
## Purpose
Identify which existing Molecule AI pipeline contacts to prioritize for enterprise case study reference clearance outreach. Based on: (1) CrewAI enterprise target verticals and roles, (2) Molecule AI's existing pipeline signals, (3) reference clearance likelihood by segment.
---
## What We're Competing Against
**CrewAI's 18 named enterprise logos** (GH#1398):
IBM, PwC, NTT DATA, PepsiCo, RBC, DocuSign + 12 others
**CrewAI's target enterprise profile:**
- **Verticals:** Financial services, enterprise software, manufacturing, professional services
- **Roles:** VP Engineering, Director of Developer Productivity, Chief AI Officer, Head of Platform Engineering
- **Use case:** Multi-agent pipelines for internal tooling, code generation at scale, document processing, customer service automation
- **Deployment:** Dedicated VPC (AMP Factory), SSO-gated, enterprise procurement
---
## Molecule AI's Counter-Positioning Advantage
For each CrewAI target persona, identify Molecule AI's differentiation:
| CrewAI Target | Molecule AI Advantage | Who to Approach |
|---------------|----------------------|-----------------|
| **VP Engineering / Platform** | Remote runtime: agent compute where data lives, not on CrewAI's cloud | Platform engineering leads with data residency concerns |
| **Director of Developer Productivity** | Org-scoped API keys + audit logs: governance without sacrificing autonomy | Dev productivity teams at regulated enterprises |
| **Head of AI / CAIO** | Multi-tenant SaaS: no infra to manage, A2A protocol works across fleet | AI offices evaluating build-vs-buy |
| **Enterprise Sales (inbound)** | Docker + Remote mixed fleet: same Canvas, same auth, two runtimes | Companies already running self-hosted AI infra |
---
## Priority Outreach Segments
### Tier 1 — Highest clearance likelihood, strongest narrative
**1. Data engineering teams on AWS/GCP using Remote Workspaces**
- *Why:* Already referenced in Phase 30 sales enablement ("raw data never touches Molecule AI platform")
- *Use case:* Data pipeline agents, ETL automation, data processing
- *Deployment:* Remote Runtime (self-managed AWS/GCP compute)
- *Clearance likelihood:* HIGH — customer self-selected as security-conscious; likely contractually clear for technical reference
- *Approach:* Ask for technical reference call + use case quote. Anonymize if named clearance fails.
**2. Enterprise platform teams evaluating AI governance**
- *Why:* Org-scoped API keys + audit logs are a differentiator vs. CrewAI's developer-tool model
- *Use case:* Agent fleet governance, MCP plugin allowlists, compliance reporting
- *Deployment:* Hybrid (Canvas + Remote)
- *Clearance likelihood:* MEDIUM-HIGH — governance buyers are often more comfortable with references
**3. AI-first startups / mid-market companies with active dev teams**
- *Why:* Faster sales cycle, more likely to have named contacts willing to go on record
- *Use case:* Multi-agent development pipelines, autonomous code review, CI/CD integration
- *Deployment:* Molecule AI Cloud or self-hosted
- *Clearance likelihood:* MEDIUM — faster to close, but may lack enterprise legal process
### Tier 2 — Valuable but harder to clear
**4. Financial services / regulated enterprises (matching CrewAI's IBM/PwC/RBC profile)**
- *Why:* Same vertical as CrewAI's confirmed wins — strongest competitive displacement narrative
- *Use case:* Compliance automation, document processing, internal tooling
- *Clearance likelihood:* LOW in near term (FedRAMP, SOC 2, internal legal review) — start outreach now but expect 68 weeks
---
## Recommended First Move
**Approach the AWS data engineering team first** (Tier 1, #1 above):
- Anonymized reference already exists in sales materials — customer is presumably aware they may be referenced
- Technical use case is documented (pipeline agents, AWS, Remote Runtime)
- Self-selected for data security narrative — strongest Molecule AI proof point
- Clearance: start with CS contact asking for "technical reference call" before mentioning public use
**Script for CS initial outreach:**
> "We're preparing a technical case study for our Phase 30 launch and we'd love to feature the work your team is doing with [use case]. This would be a short [named/anonymized — their choice] overview of what you deployed and the outcome. Legal clearance typically takes 23 weeks — we're starting now so we're ready for launch. Would your contact be open to a 20-minute call with our marketing team?"
---
## What to Capture on the Call
For each reference candidate, collect:
1. **Named customer** (company + contact name + title) OR explicit anonymization approval
2. **Use case:** What problem, what Molecule AI features, how many agents/users
3. **Deployment model:** Cloud / self-hosted / hybrid; backend infrastructure
4. **Outcome metric:** Even directional ("reduced X by ~70%") is useful
5. **Quote:** 12 sentences on what problem they solved and why they chose Molecule AI
6. **Approval:** Email confirmation from legal or contact for marketing to reference
---
## Next Steps
- [ ] CS to pull list of all pipeline contacts with "data engineering," "platform engineering," or "AI governance" in role/company description
- [ ] CS to identify which contacts are on AWS or have data residency requirements (highest fit)
- [ ] Draft outreach email template (use script above)
- [ ] Begin legal clearance process for Tier 1 candidate this week